Atlas Trials

Treatment Resistance Following Anti-cancer Therapies

Clinical trial NCT04436120 · TERMINATED

Trial details

NCT number
NCT04436120
Sponsor
Pfizer
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Disease Progression
Start date
2019-02-13
Primary completion
2020-12-14
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.